Global Thiocolchicosie Market Insights, Forecast to 2028
SKU ID : QYR-20482127 | Publishing Date : 14-Mar-2022 | No. of pages : 89
Market Analysis and Insights: Global Thiocolchicosie Market
Due to the COVID-19 pandemic, the global Thiocolchicosie market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Injection Products accounting for % of the Thiocolchicosie global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Thiocolchicosie market size is valued at US$ million in 2021, while the US and Europe Thiocolchicosie are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Thiocolchicosie landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Thiocolchicosie include Alchem International Ltd, Alkaloids Pvt. Ltd, SARV BIO LABS PVT LTD, HINDUSTAN HERBALS LTD, Supriya Lifescience Limited, Hubei Dixin Chemical, Festiva Pharma and Haihang Industry, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Thiocolchicosie Scope and Segment
Thiocolchicosie market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Thiocolchicosie market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Injection Products
Capsule Products
Tablet Products
Others
Segment by Application
Hospital
Clinics
Drug Store
Others
By Company
Alchem International Ltd
Alkaloids Pvt. Ltd
SARV BIO LABS PVT LTD
HINDUSTAN HERBALS LTD
Supriya Lifescience Limited
Hubei Dixin Chemical
Festiva Pharma
Haihang Industry
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Frequently Asked Questions
- By product type
- By End User/Applications
- By Technology
- By Region